GSK finds axing doctor payments needn't torpedo sales
April 27, 2016 at 09:56 AM EDT
LONDON, April 27 (Reuters) - It has been one of the pharmaceutical industry's most closely watched experiments: does ending payments to doctors undermine drug sales?